S Chabra, B J Gill, G Gallo, D Zhu, C Pitou, C D Payne, A Accioly, L Puig
Issues - Maggio 2022
S Chabra, B J Gill, G Gallo, D Zhu, C Pitou, C D Payne, A Accioly, L Puig
V Di Lernia, L Macca, L Peterle, Y Ingrasciotta, G Trifirò, C Guarneri
Efficacy of systemic biologic drugs in pediatric psoriasis: Evidence from five selected randomized clinical trials
Front Pharmacol. 2022 Apr 5;13:847308E Sahin, M Hawro, K Weller, R Sabat, S Philipp, G Kokolakis, D Christou, M Metz, M Maurer, T Hawro
Prevalence and factors associated with sleep disturbance in adult patients with psoriasis
J Eur Acad Dermatol Venereol. 2022 May;36(5):688-697A Norden, S Rekhtman, A Strunk, A Garg
Risk of psoriasis according to body mass index: A retrospective cohort analysis
J Am Acad Dermatol. 2022 May;86(5):1020-1026C Choonhakarn, S Chaowattanapanit, N Julanon, P Limpawattana
Comparison of the clinical efficacy of subcutaneous vs. oral administration of methotrexate in patients with psoriasis vulgaris: A randomized controlled trial
Clin Exp Dermatol. 2022 May;47(5):942-948A B Gottlieb, A Deodhar, I B Mcinnes, X Baraliakos, K Reich, S Schreiber, W Bao, K Marfo, H B Richards, L Pricop, A Shete, V Trivedi, D Keefe, C C Papavassilis, P Jagiello, P Papanastasiou, P J Mease, M Lebwohl
Long-term safety of secukinumab over five years in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis: update on integrated pooled clinical trial and post-marketing surveillance data
Acta Derm Venereol. 2022 Apr 27;102:adv00698K Reich, D Thaçi, G Stingl, J S Andersen, L C Hiort, M O Lexner, D Winkler, C Paul
Safety of brodalumab in plaque psoriasis: Integrated pooled data from five clinical trials
Acta Derm Venereol. 2022 Mar 28;102:adv00683V Viswanath, P Joshi, P Lawate, D Tare, D Dhoot, N Mahadkar, H Barkate
An open-label, randomized, prospective, comparative, three-arm clinical trial to evaluate the safety and effectiveness of apremilast with three different titration methods in patients with chronic plaque psoriasis in India
Psoriasis (Auckl). 2022 Apr 22;12:53-61Z D Draelos
The efficacy and tolerability of turmeric and salicylic acid in psoriasis treatment
Psoriasis (Auckl). 2022 Apr 29;12:63-71S Löfvendahl, J M Norlin, M Schmitt-Egenolf
Economic burden of generalized pustular psoriasis in sweden: A population-based register study
Psoriasis (Auckl). 2022;12:89-98K Xue, S Shao, H Fang, L Ma, C Li, Z Lu, G Wang
Adipocyte-derived CTRP3 exhibits anti-inflammatory effects via lamp1-stat3 axis in psoriasis
J Invest Dermatol. 2022 May;142(5):1349-1359.e8T Khosravi-Hafshejani, M Ghoreishi, C V Kellet, R I Crawford, M Martinka, J P Dutz
Small plaque psoriasis re-visited: A type of psoriasis mediated by a type-I interferon pathway
Exp Dermatol. 2022 May;31(5):753-763F Bellinato, G Adami, S Vaienti, C Benini, D Gatti, L Idolazzi, A Fassio, M Rossini, G Girolomoni, P Gisondi
Association between short-term exposure to environmental air pollution and psoriasis flare
JAMA Dermatol. 2022 Apr 1;158(4):375-381C Xu, A Teeple, B Wu, T Fitzgerald, S R Feldman
Drug adherence and persistence of patients with moderate to severe psoriasis treated with biologic medications in a us commercially insured population
Dermatology. 2022;238(3):438-447J H Han, J W Park, K D Han, J B Park, M Kim, J H Lee
Smoking and periodontitis can play a synergistic role in the development of psoriasis: A nationwide cohort study
Dermatology. 2022;238(3):554-561H J Lee, K Han, H Soh, S-J Koh, J P Im, J S Kim, H E Park, M Kim